Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06172270
Other study ID # 2023-0555
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2023
Est. completion date December 1, 2024

Study information

Verified date November 2023
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Yuhan Fu
Phone 18857168333
Email huangpintong@126.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to investigate breast cancer's internal heterogeneity and enhance diagnostic accuracy. We aim to achieve this by utilizing Contrast-Enhanced Ultrasound (CEUS) technology, which provides detailed information about tumor perfusion dynamics. Traditional biopsy methods have limitations due to the invasive nature and complexity of breast cancer heterogeneity. Participants in this study will undergo preoperative breast cancer diagnosis using CEUS technology, which is safe, cost-effective, and convenient. Dynamic CEUS videos will be used to cluster perfusion characteristics at the pixel level within breast tumors, allowing us to divide the tumors into distinct subregions based on these clusters. We will then explore the correlation between these perfusion subregions and the diagnosis of benign or malignant breast tumors. Our ultimate aim is to develop diagnostic models that utilize non-invasive imaging data to enhance breast cancer diagnosis. This approach reduces subjective judgments in the diagnostic process, potentially improving diagnostic accuracy. It also provides valuable information for personalized treatment decisions, thus advancing the field of breast cancer treatment.


Description:

Breast cancer is one of the most prevalent cancers among women globally, and its increasing incidence poses a significant threat to women's health. Despite notable advances in early diagnosis and treatment due to the continuous progress in medical technology, the high heterogeneity within breast cancer still results in considerable variability in clinical manifestations, treatment responses, and disease progression. This diversity presents new challenges in achieving precise treatment. Thus, a profound exploration and study of the heterogeneity of breast cancer are crucial for developing more effective diagnostic models, advancing treatment strategies, and enhancing cure rates. In current clinical practice, although biopsy is widely used for the diagnosis of benign or malignant breast tumors, its accuracy and comprehensiveness are somewhat limited due to the complex internal heterogeneity of breast cancer and the invasive nature of the procedure. In recent years, preoperative qualitative diagnosis of breast cancer using medical imaging technology has become a hot topic in research. Compared with other common imaging techniques such as CT and MRI, ultrasound examination is extensively employed due to its safety, convenience, and lower cost. Particularly, Contrast-Enhanced Ultrasound (CEUS) technology, with its superior temporal resolution, can vividly illustrate the details of tumor perfusion hemodynamics, effectively revealing key features such as enhancement patterns, blood supply, and vascular invasion of the tumor. This study is dedicated to using dynamic CEUS videos to cluster perfusion characteristics at the pixel level within the tumor and divide the tumor into different subregions based on the clustering results. We will explore the correlation between these perfusion subregions and the diagnosis of benign or malignant breast tumors, and based on this, develop related diagnostic models. This non-invasive diagnostic approach aims to maximally mine and utilize image data, comprehensively capturing the tumor's perfusion characteristics at the pixel level, and reducing subjective judgments in the diagnostic process. The application of this method is not only expected to improve the accuracy of breast cancer diagnosis but also to provide more information support for personalized treatment of patients, thereby promoting progress in the field of breast cancer treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 1, 2024
Est. primary completion date December 1, 2024
Accepts healthy volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Prospective cohort patients voluntarily sign an informed consent form. - Patients who undergo breast contrast-enhanced ultrasound. - Patients with breast nodules that have not received any treatment. Exclusion Criteria: - Patients who cannot obtain pathological results due to refusal of further diagnosis or treatment. - Patients whose breast lesions are too large to display their long axis under the ultrasound probe. - Patients contraindicated for contrast-enhanced ultrasound. - Historical cohort patients who cannot obtain ultrasound contrast videos of at least 45-60 seconds post contrast agent injection. - Patients whose ultrasound contrast videos show excessive motion displacement that cannot be corrected.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy The proportion of breast tumors (benign or malignant) correctly classified by the diagnostic model. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05544123 - The Treatment Situation of Chinese County Population With Breast Cancer
Completed NCT01881230 - Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) Phase 2/Phase 3
Withdrawn NCT05191004 - Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC Phase 1/Phase 2
Active, not recruiting NCT01247480 - Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer N/A
Recruiting NCT04626986 - Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor N/A
Completed NCT04805775 - Desflurane and Postoperative Sleep Quality in Patients Undergoing Elective Breast Surgery N/A
Recruiting NCT03347864 - 68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients Early Phase 1
Completed NCT03684408 - Radiofrequency Chip for Localization of Non-Palpable Breast Lesions N/A
Recruiting NCT04692818 - 3D Ultrasound Breast Imaging N/A
Not yet recruiting NCT04825444 - Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Withdrawn NCT02470819 - Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer N/A
Completed NCT00859261 - Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound N/A
Active, not recruiting NCT05169437 - Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Phase 2
Recruiting NCT03870620 - Metastatic Breast Cancer in Austria
Completed NCT05185752 - Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery N/A
Recruiting NCT04852926 - Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.
Recruiting NCT04948983 - The Effect of a Patient Decision Aids for Breast Cancer Screening N/A
Not yet recruiting NCT06251544 - TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer Phase 1
Terminated NCT02364960 - Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)